Exploring how lung cancer cells present antigens to the immune system
Interrogating the relationship between translational dynamics and non-canonical antigen presentation in lung cancer
This study is looking at how lung cancer cells show certain markers to the immune system, especially to important immune cells called CD8+ T cells, to help find new ways to make cancer treatments more effective and personalized for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | H. Lee Moffitt Cancer Ctr & Res Inst NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-10943035 on NIH RePORTER |
What this research studies
This research investigates how lung cancer cells present specific antigens to the immune system, particularly focusing on CD8+ T cells, which are crucial for targeting cancer. By utilizing advanced mass spectrometry techniques, the study aims to identify a broader range of cancer-specific antigens, including those derived from novel genetic sequences. This approach seeks to enhance the effectiveness of immunotherapies by understanding the diverse sources of antigens that can stimulate immune responses against tumors. Patients may benefit from insights that could lead to more personalized and effective cancer treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are lung cancer patients, particularly those with low tumor mutation burdens who may not respond well to traditional therapies.
Not a fit: Patients with cancers that do not involve the mechanisms of antigen presentation being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved immunotherapy options for lung cancer patients by identifying new targets for treatment.
How similar studies have performed: Previous research has shown promise in identifying novel antigens for immunotherapy, suggesting that this approach could yield significant advancements.
Where this research is happening
Tampa, United States
- H. Lee Moffitt Cancer Ctr & Res Inst — Tampa, United States (Active)
Researchers
- Principal investigator: Jaeger, Alex — H. Lee Moffitt Cancer Ctr & Res Inst
- Study coordinator: Jaeger, Alex
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.